Callan Family Office’s Steris STE Stock Holding History
Bought
Maintained
Sold
Other funds holding STE
VCM
VPM
OAG
GIM
Callan Family Office's STE Position: Q1 2026 in Review
Callan Family Office reduced its Steris (STE) stake by 37% in Q1 2026, selling an estimated $303K and leaving 2,081 shares worth $460K. The position accounts for 0.01% of the portfolio, ranked #793.
Callan Family Office first reported a position in STE in Q2 2025 and has held it in 4 quarters since. The position peaked at $842K in Q4 2025. 838 funds tracked by Wall St. Rank hold STE as of Q1 2026.
- Callan Family Office held 2,081 shares of Steris worth $460K as of Q1 2026.
- Callan Family Office sold 1,239 Steris shares in Q1 2026, an estimated $303K.
- Steris made up 0.01% of Callan Family Office's portfolio in Q1 2026, its #793 holding.
- Callan Family Office first reported a position in Steris in Q2 2025 and has held it in 4 quarters since.
- Callan Family Office's Steris position peaked at $842K in Q4 2025.
- 838 funds tracked by Wall St. Rank held Steris as of Q1 2026.
Based on Callan Family Office's 13F filing for Q1 2026, filed 13 May 2026.